| Cost of Prescription Drug-Related Morbidity and Mortality |
28 |
| Cannabidiol: A New Hope for Patients With Dravet or Lennox-Gastaut Syndromes |
22 |
| Baricitinib: The Second FDA-Approved JAK Inhibitor for the Treatment of Rheumatoid Arthritis |
20 |
| Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation |
19 |
| Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease |
14 |
| Associations Between Potentially Inappropriate Medications and Adverse Health Outcomes in the Elderly: A Systematic Review and Meta-analysis |
13 |
| Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals |
12 |
| Comparison of the Nephrotoxicity of Vancomycin in Combination With Cefepime, Meropenem, or Piperacillin/Tazobactam: A Prospective, Multicenter Study |
12 |
| Optimizing the Treatment of Steroid-Induced Hyperglycemia |
12 |
| Medication Regimen Complexity Measured by MRCI: A Systematic Review to Identify Health Outcomes |
11 |
| Critical Care Pharmacists and Medication Management in an ICU Recovery Center |
11 |
| Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine |
10 |
| Critical Review of Double-Carbapenem Therapy for the Treatment of Carbapenemase-Producing Klebsiella pneumoniae |
9 |
| Vancomycin Prophylaxis for Prevention of Clostridium difficile Infection Recurrence in Renal Transplant Patients |
9 |
| Continuous Care Provided Through Comprehensive Medication Management in an Acute Care Practice Model |
8 |
| Copanlisib: An Intravenous Phosphatidylinositol 3-Kinase (PI3K) Inhibitor for the Treatment of Relapsed Follicular Lymphoma |
8 |
| Sarilumab: Review of a Second IL-6 Receptor Antagonist Indicated for the Treatment of Rheumatoid Arthritis |
8 |
| Effective Interventions for Diabetes Patients by Community Pharmacists: A Meta-analysis of Pharmaceutical Care Components |
8 |
| Enoxaparin Dosing at Extremes of Weight: Literature Review and Dosing Recommendations |
7 |
| Nusinersen: A Treatment for Spinal Muscular Atrophy |
7 |
| A Review of ACE Inhibitors and ARBs in Black Patients With Hypertension |
7 |
| Eravacycline: The Tetracyclines Strike Back |
6 |
| Sodium-Glucose Cotransporters as Potential Therapeutic Targets in Patients With Type 1 Diabetes Mellitus: An Update on Phase 3 Clinical Trial Data |
6 |
| Medication Regimen Complexity and Hospital Readmission in Older Adults With Chronic Kidney Disease |
6 |
| Direct Oral Anticoagulants in Chronic Liver Disease |
6 |
| Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions |
6 |
| Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week Data |
6 |
| Influence of Direct Oral Anticoagulants on Anti-Factor Xa Measurements Utilized for Monitoring Heparin |
6 |
| Dietary Supplement Adverse Event Report Data From the FDA Center for Food Safety and Applied Nutrition Adverse Event Reporting System (CAERS), 2004-2013 |
6 |
| Baloxavir Marboxil: The First Cap-Dependent Endonuclease Inhibitor for the Treatment of Influenza |
6 |
| Anti-Xa Oral Anticoagulant Plasma Concentration Assay in Real Life: Rivaroxaban and Apixaban Quantification in Emergency With LMWH Calibrator |
5 |
| Tildrakizumab: A Review of Phase II and III Clinical Trials |
5 |
| Denosumab: A Unique Perspective on Adherence and Cost-effectiveness Compared With Oral Bisphosphonates in Osteoporosis Patients |
5 |
| Treatment Persistence Among Insured Patients Newly Starting Buprenorphine/Naloxone for Opioid Use Disorder |
5 |
| Evaluating the Impact of the Addition of Cladribine to Standard Acute Myeloid Leukemia Induction Therapy |
5 |
| Perioperative Bridging With Glycoprotein IIb/IIIa Inhibitors Versus Cangrelor: Balancing Efficacy and Safety |
5 |
| Gender Differences in Efficacy and Safety of Direct Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Network Meta-analysis |
5 |
| Clinical Management of Bleeding Risk With Antidepressants |
5 |
| Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections |
5 |
| The Risk of Community-Acquired Enteric Infection in Proton Pump Inhibitor Therapy: Systematic Review and Meta-analysis |
5 |
| Impact of Vitamin D Supplementation on Attention-Deficit Hyperactivity Disorder in Children |
5 |
| Drug-Induced Restless Legs Syndrome |
5 |
| Outcomes of a Pharmacist-Managed Heart Failure Medication Titration Assistance Clinic |
5 |
| Neratinib in HER2-Positive Breast Cancer Patients |
5 |
| Brigatinib: Novel ALK Inhibitor for Non-Small-Cell Lung Cancer |
5 |
| Association Between Drug Exposure and Occurrence of Parkinsonism in Korea: A Population-Based Case-Control Study |
5 |
| Dolutegravir Dual Therapy as Maintenance Treatment in HIV-Infected Patients: A Review |
4 |
| Evaluating the Impact of a Clinical Decision Support Tool to Reduce Chronic Opioid Dose and Decrease Risk Classification in a Veteran Population |
4 |
| Clinical Safety Outcomes in Patients With Nonvalvular Atrial Fibrillation on Rivaroxaban and Diltiazem |
4 |
| HIV Clinical Updates: New Single-Tablet Regimens |
4 |
